Effect of the tyramine fragment of opioid receptor ligands on their agonist and antagonist properties

Author： Kuz’mina N.   Osipova E.   Kuz’min V.   Sitnikov V.  

Publisher： Springer Publishing Company

ISSN： 0091-150X

Source： Pharmaceutical Chemistry Journal, Vol.40, Iss.5, 2006-05, pp. : 254-260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strategies for the Design of Non-peptide CCK2 Receptor Agonist and Antagonist Ligands

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 12, 2007-06 ,pp. : 1195-1204

Bentham Science Publishers

Access to resources Recommend Favorite

Analgesic effects of Tyr-W-MIF-1: a mixed 2 -opioid receptor agonist/ 1 -opioid receptor antagonist

By Gergen K.A.   Zadina J.E.   Paul D.  

European Journal of Pharmacology, Vol. 316, Iss. 1, 1996-11 ,pp. : 33-38

Elsevier

Access to resources Recommend Favorite

Activation of c-fos mRNA in the brain by the -opioid receptor agonist enadoline and the NMDA receptor antagonist dizocilpine

By Panegyres P.K.   Hughes J.  

European Journal of Pharmacology, Vol. 328, Iss. 1, 1997-09 ,pp. : 31-36

Elsevier

Access to resources Recommend Favorite

Pharmacological Properties of Novel Cyclic Pentapeptides with μ-opioid Receptor Agonist Activity

By  

Medicinal Chemistry, Vol. 10, Iss. 2, 2014-03 ,pp. : 154-161

Bentham Science Publishers

Access to resources Recommend Favorite

Kappa-opioid receptor ligands

By Husbands Stephen M  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 12, 2004-12 ,pp. : 1725-1741

Informa Healthcare

Access to resources Recommend Favorite